|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carcas LP: Gastric cancer review. J
Carcinog. 13:142014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen J, Xie F, Zhang L and Jiang WG: iASPP
is over-expressed in human non-small cell lung cancer and regulates
the proliferation of lung cancer cells through a p53 associated
pathway. BMC Cancer. 10:6942010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dong P, Ihira K, Hamada J, Watari H,
Yamada T, Hosaka M, Hanley SJ, Kudo M and Sakuragi N: Reactivating
p53 functions by suppressing its novel inhibitor iASPP: A potential
therapeutic opportunity in p53 wild-type tumors. Oncotarget.
6:19968–19975. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duffy MJ, Synnott NC, McGowan PM, Crown J,
O'Connor D and Gallagher WM: p53 as a target for the treatment of
cancer. Cancer Treat Rev. 40:1153–1160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meek DW: Regulation of the p53 response
and its relationship to cancer. Biochem J. 469:325–346. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laska MJ, Vogel UB, Jensen UB and Nexø BA:
p53 and PPP1R13L (alias iASPP or RAI) form a feedback loop to
regulate genotoxic stress responses. Biochim Biophys Acta 1800:.
1231:12402010.
|
|
8
|
Wang C, Gao C, Chen Y, Yin J, Wang P and
Lv X: Expression pattern of the apoptosis-stimulating protein of
p53 family in p53+ human breast cancer cell lines. Cancer Cell Int.
13:1162013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu H, Wang M, Diao S, Rao Q, Zhang X,
Xing H and Wang J: siRNA-mediated down-regulation of iASPP promotes
apoptosis induced by etoposide and daunorubicin in leukemia cells
expressing wild-type p53. Leuk Res. 33:1243–1248. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, Xie F, Zhang L and Jiang WG: iASPP
is over-expressed in human non-small cell lung cancer and regulates
the proliferation of lung cancer cells through a p53 associated
pathway. BMC Cancer. 10:6942010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin BL, Xie DY, Xie SB, Xie JQ, Zhang XH,
Zhang YF and Gao ZL: Down-regulation of iASPP in human
hepatocellular carcinoma cells inhibits cell proliferation and
tumor growth. Neoplasma. 58:205–210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meng WD, Chu RX, Wang BZ, Wang LP, Ma LL
and Wang LX: Helicobacter pylori infection and expressions of
apoptosis-related proteins p53, ASPP2 and iASPP in gastric cancer
and precancerous lesions. Pathol Biol. 61:199–202. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Berloco P, Russo F, Cariola F, Gentile M,
Giorgio P, Caruso ML, Valentini AM, Di Matteo G and Di Leo A: Low
presence of p53 abnormalities in H. pylori-infected gastric mucosa
and in gastric adenocarcinoma. J Gastroenterol. 38:28–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cai Y, Qiu S, Gao X, Gu SZ and Liu ZJ:
iASPP inhibits p53-independent apoptosis by inhibiting
transcriptional activity of p63/p73 on promoters of proapoptotic
genes. Apoptosis. 17:777–783. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gillotin S and Lu X: The ASPP proteins
complex and cooperate with p300 to modulate the transcriptional
activity of p53. FEBS Lett. 585:1778–1782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee HY, Ahn JB, Rha SY, Chung HC, Park KH,
Kim TS, Kim NK and Shin SJ: High KLF4 level in normal tissue
predicts poor survival in colorectal cancer patients. World J Surg
Oncol. 12:2322014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghaleb AM and Yang VW: Krüppel-like factor
4 (KLF4): What we currently know. Gene. 611:27–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Foster KW, Ren S, Louro ID, Lobo-Ruppert
SM, McKie-Bell P, Grizzle W, Hayes MR, Broker TR, Chow LT and
Ruppert JM: Oncogene expression cloning by retroviral transduction
of adenovirus E1A-immortalized rat kidney RK3E cells:
Transformation of a host with epithelial features by c-MYC and the
zinc finger protein GKLF. Cell Growth Differ. 10:423–434.
1999.PubMed/NCBI
|
|
19
|
Foster KW, Frost AR, McKie-Bell P, Lin CY,
Engler JA, Grizzle WE and Ruppert JM: Increase of GKLF messenger
RNA and protein expression during progression of breast cancer.
Cancer Res. 60:6488–6495. 2000.PubMed/NCBI
|
|
20
|
Ton-That H, Kaestner KH, Shields JM,
Mahatanankoon CS and Yang VW: Expression of the gut-enriched
Krüppel-like factor gene during development and intestinal
tumorigenesis. FEBS Lett. 419:239–243. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao W, Hisamuddin IM, Nandan MO, Babbin
BA, Lamb NE and Yang VW: Identification of Krüppel-like factor 4 as
a potential tumor suppressor gene in colorectal cancer. Oncogene.
23:395–402. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsu LS, Chan CP, Chen CJ, Lin SH, Lai MT,
Hsu JD, Yeh KT and Soon MS: Decreased s-like factor 4 (KLF4)
expression may correlate with poor survival in gastric
adenocarcinoma. Med Oncol. 30:6322013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ohnishi S, Ohnami S, Laub F, Aoki K,
Suzuki K, Kanai Y, Haga K, Asaka M, Ramirez F and Yoshida T:
Downregulation and growth inhibitory effect of epithelial-type
Krüppel-like transcription factor KLF4, but not KLF5, in bladder
cancer. Biochem Biophys Res Commun. 308:251–256. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang WT and Zheng PS: Kruppel-like factor
4 function as a tumor suppressor in cervical carcinoma. Cancer.
118:3691–3702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krstic M, Stojnev S, Jovanovic L and
Marjanovic G: KLF4 expression and apoptosis-related markers in
gastric cancer. J BUON. 18:695–702. 2013.PubMed/NCBI
|
|
26
|
Kaczynski J, Cook T and Urrutia R: Sp1-
and Krüppel-like transcription factors. Genome Biol. 4:2062003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Black AR, Black JD and Azizkhan-Clifford
J: Sp1 and krüppel-like factor family of transcription factors in
cell growth regulation and cancer. J Cell Physiol. 188:143–160.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Elemento O: KLF4: A new player in plasma
cell development. Cell Cycle. 15:2691–2692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brosh R, Assia-Alroy Y, Molchadsky A,
Bornstein C, Dekel E, Madar S, Shetzer Y, Rivlin N, Goldfinger N,
Sarig R and Rotter V: p53 counteracts reprogramming by inhibiting
mesenchymal-to-epithelial transition. Cell Death Differ.
20:312–320. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yokozaki H: Molecular characteristics of
eight gastric cancer cell lines established in Japan. Pathol Int.
50:767–777. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sigal A and Rotter V: Oncogenic mutations
of the p53 tumor suppressor: The demons of the guardian of the
genome. Cancer Res. 60:6788–6793. 2000.PubMed/NCBI
|
|
32
|
Zhang SW, Xiao SW and Lü YY:
Adenovirus-mediated P53 cancer transfer increases the
thermosensitivity of human gastric carcinoma cell lines in vitro
and in vivo. Chin J Cancer Res. 15:107–111. 2003. View Article : Google Scholar
|
|
33
|
Liu J, Zhang Y, Xie YS, Wang FL, Zhang LJ,
Deng T and Luo HS: 5-Aza-2′-deoxycytidine induces cytotoxicity in
BGC-823 cells via DNA methyltransferase 1 and 3a independent of p53
status. Oncol Rep. 28:545–552. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li G, Wang R, Gao J, Deng K, Wei J and Wei
Y: RNA interference-mediated silencing of iASPP induces cell
proliferation inhibition and G0/G1 cell cycle arrest in U251 human
glioblastoma cells. Mol Cell Biochem. 350:193–200. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen J, Xiao H, Huang Z, Hu Z, Qi T, Zhang
B and Liu SH: MicroRNA124 regulate cell growth of prostate cancer
cells by targeting iASPP. Int J Clin Exp Pathol. 7:2283–2290.
2014.PubMed/NCBI
|
|
37
|
Li S, Shi G, Yuan H, Zhou T, Zhang Q, Zhu
H and Wang X: Abnormal expression pattern of the ASPP family of
proteins in human non-small cell lung cancer and regulatory
functions on apoptosis through p53 by iASPP. Oncol Rep. 28:133–140.
2012.PubMed/NCBI
|
|
38
|
Grabenbauer GG, Suckorada O, Niedobitek G,
Rödel F, Iro H, Sauer R, Rödel C, Schultze-Mosgau S and Distel L:
Imbalance between proliferation and apoptosis may be responsible
for treatment failure after postoperative radiotherapy in squamous
cell carcinoma of the oropharynx. Oral Oncol. 39:459–469. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu H, Wang M, Diao S, Rao Q, Zhang X,
Xing H and Wang J: siRNA-mediated down-regulation of iASPP promotes
apoptosis induced by etoposide and daunorubicin in leukemia cells
expressing wild-type p53. Leuk Res. 33:1243–1248. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen J, Xie F, Zhang L and Jiang WG: iASPP
is over-expressed in human non-small cell lung cancer and regulates
the proliferation of lung cancer cells through a p53 associated
pathway. BMC Cancer. 10:6942010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang LL, Xu Z, Peng Y, Li LC and Wu XL:
Downregulation of inhibitor of apoptosis-stimulating protein of p53
inhibits proliferation and promotes apoptosis of gastric cancer
cells. Mol Med Rep. 12:1653–1658. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sullivan A and Lu X: ASPP: A new family of
oncogenes and tumour suppressor genes. Br J Cancer. 96:196–200.
2007. View Article : Google Scholar : PubMed/NCBI
|
